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The purpose of the ELDCARE project is to study differences in cancer survival for elderly
patients by country, taking into account the socio-economic conditions and the character-
istics of health care systems at the ecological level. Fifty-three European cancer registries,
from 19 countries, participating in the EUROCARE 3 programme, collected information to
compute relative survival on patients aged 65–84 years, diagnosed over the period 1990–
1994. National statistics offices provided the macro-economic and labour force indicators
(gross domestic product, total health expenditure, and proportion of people employed in
the agriculture sector) as well as the features of national health care systems. Survival
for several of the cancer sites had high positive Pearson’s correlations (r) with the affluence
indicators (usually r > 0.7), but survival for the poor prognosis cancers (lung, ovary, stom-
ach) and for cervix uteri was not so well correlated. Among the medical resources consid-
ered, the number of computed tomography scanners was the variable most related to
survival in the elderly; the number of total health practitioners in the country did not show
any relationship. Survival was related to the marital status of elderly women more strongly
than for men and younger people. The highest correlations of survival with the percentage
of married elderly women in the population were for cancers of the rectum (r = 0.79) and
breast (r = 0.66), while survival correlated negatively with the proportion of widows forer Ltd. All rights reserved.
; fax: +39 010 5600956.
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E U R O P E A N J O U R N A L O F C A N C E R 4 2 ( 2 0 0 6 ) 2 3 4 –2 4 2 235most cancers. Being married or widowed is for elderly people, in particular elderly women,
an important factor influencing psychological status, life habits and social relationships.
Social conditions could play a major role in determining health outcomes, particularly in
the elderly, by affecting access to health care and delay in diagnosis.
 2005 Elsevier Ltd. All rights reserved.1. Introduction
The EUROCARE I and II studies, at the time of their publica-
tion the largest population-based studies investigating cancer
survival in Europe, revealed important geographical varia-
tions in survival among European countries for all cancer
sites [1,2]. The variation was, however, different in younger
and older patients, depending on the general prognosis of
each cancer [3].
In addition, very large and unexpected differences in sur-
vival between the elderly and younger adults were observed.
Elderly patients, those aged 65 years or over, had much poorer
survival rates than younger adults, particularly at one year
after diagnosis. The relative disadvantage of elderly patients
was more noticeable in women generally and for gynaecolog-
ical cancers in particular [4,5].
These findings suggest a possible role played by stage of
disease at presentation and the importance of social support
as well as access to health care, all of which are strongly influ-
enced by socio-economic factors. Influential experts in geriat-
ric oncology consider that large systematic studies are
warranted in two important areas: clinical response to cancer
treatment in the presence of the normal physiological ageing
process and co-morbidities; and the psychological resources
and socio-economic support used by the elderly to cope with
the effects of cancer and its treatment [6].
Very marked ecological correlations have been observed
between some socio-economic factors and survival for pa-
tients of all ages combined for various cancers [3]. Other stud-
ies however, did not find a link between socio-economic
factors and health outcomes in the elderly [7–9]. These con-
tradictory results probably arise from the differences in the
indicators used to measure health outcomes [10].
The ELDCARE project is an ecological study specifically
planned to describe and understand the relationships be-
tween cancer survival in the elderly and both socio-economic
conditions and the characteristics of health care systems in a
large number of European countries.
The basis and the main features of this project have been
described in a previous publication [11]. That paper focused
on the description of the database and on the analysis of
the relationships between cancer survival and various char-
acteristics of the health systems in different countries. The
present paper examines the relationships between cancer
survival and socio-economic factors for 11 major cancers.
2. Patients and methods
Incidence and follow-up data, used for computing survival
rates, were obtained from EUROCARE 3, the largest study ever
carried out to investigate cancer survival in Europe [12]. Forour study, only elderly patients, those aged from 65 to 84
years, were considered. This choice of age range was intended
to help overcome some of the well known problems with sta-
tistics in the very elderly, which are often not reliable due to
the lower completeness and poorer quality of collection and
registration [5,13].
The incidence data for cancers of the stomach, colon, rec-
tum, lung, melanoma, breast, cervix and corpus uteri, ovary
and prostate, and non-Hodgkin’s lymphoma (NHL) related to
657,541 elderly subjects diagnosed during the period 1990–
1994. Patients were followed up for at least five years in or-
der to assess their vital status. Those patients recorded by
the cancer registries (CRs) only through information from a
death certificate (DCO cases) were excluded from the sur-
vival analysis. Information from death certificates mention-
ing cancer is used by CRs as a basis for ‘‘tracing back’’ (in
time) and ascertaining cases previously not registered. Such
cases tend to have shorter survival than average (because
they died from cancer rather than an ‘‘other’’ cause). Death
certificate information was not routinely available to the reg-
istries in France, The Netherlands and Sweden. This should
be recognised as a potential cause of bias, affecting particu-
larly the oldest age groups and should be taken into account
when comparing survival rates for these three countries
with those of other countries. Data were collected by 53
CRs in 19 European countries (Denmark, Finland, Iceland,
Norway and Sweden in Northern Europe; United Kingdom;
Austria, France, Germany, Switzerland and The Netherlands
in Western Europe; Italy, Portugal and Spain in Southern Eur-
ope; Czech Republic, Estonia, Poland, Slovakia and Slovenia
in Eastern Europe). Survival rates for the United Kingdom
were calculated from the pooled data for England, Scotland
and Wales. Table 1a, for men, and Tables 1b, 1c for women,
show the numbers of cases and the relative survival at five
years from diagnosis by country.
Observed and relative survival were computed using
Hakulinen’s methods [14]. Survival for each European country
was taken to be the value for the national CR where one
existed, otherwise the figure for the pool of participating
CRs in that country was used.
The second part of the material comprises socio-economic
variables and characteristics of the national health care sys-
tems. A representative for each participating country pro-
vided data at the ecological level, relating to the whole
nation, through collection of information from national sta-
tistics offices and other official national or international
sources.
In this way, we covered several aspects of the socio-
economic field with a wide array of variables; only a few of
these factors were chosen for inclusion in the current analy-
sis. The selection procedures, and the whole database, were
Table 1a – Relative survival (%) at 5 years from diagnosis for men aged 65–84 years diagnosed during the period 1990–1994,
by cancer site and country (countries ordered by decreasing rank of total health expenditure per capita in US$ Purchasing
Parity Power)
Men Stomach Colon Rectum Lung Melanoma Prostate NHLa
RS% Cases RS% Cases RS% Cases RS% Cases RS% Cases RS% Cases RS% Cases
Switzerland 22 116 55 286 58 170 8 469 82 84 71 856 51 95
Germany 28 415 54 779 51 450 10 1291 80 86 82 1599 50 149
Franceb 20 444 55 1005 48 644 14 1227 78 84 78 2118 46 253
Denmark 10 984 44 2548 42 2067 6 5633 70 504 44 5043 40 723
Norway 18 1431 52 2353 51 1608 7 3443 72 651 63 7679 37 694
The Netherlandsb 16 872 50 1339 53 737 10 4432 79 159 70 3709 38 423
Austria 24 310 50 254 40 132 10 422 76 67 84 1009 56 49
Iceland 25 94 40 70 54 24 8 153 70 11 78 363 50 27
Swedenb 17 2477 52 4129 53 2889 7 4750 81 1307 70 19,071 44 1574
Italy 22 5036 51 5245 45 2765 9 13,188 59 516 67 8069 45 1688
Finland 19 1272 54 1045 50 996 7 4490 77 341 70 5766 36 617
United Kingdom 11 15,134 45 20,736 43 14,431 6 59,023 69 2266 54 47,155 37 6390
Spain 24 1509 55 1769 49 1162 12 4590 68 163 66 2812 50 417
Portugal 18 408 45 228 44 185 – – 58 24 48 263 39 73
Slovenia 13 666 35 468 30 479 7 1358 57 88 50 864 46 133
Czeck Republic 13 248 37 365 26 343 4 913 55 61 54 537 35 76
Slovakia 19 1635 38 1329 25 1387 6 3596 41 187 50 2157 32 240
Poland 9 736 25 605 27 460 6 2218 50 65 42 852 23 183
Estonia 15 579 35 303 31 228 6 1178 62 38 52 748 31 59
RS%, relative survival (%).
a Non-Hodgkin’s lymphoma.
b Information from death certificates not available to the cancer registries (see text).
Table 1b – Relative survival (%) at 5 years from diagnosis for women aged 65–84 years diagnosed during the period 1990–
1994, by cancer site and country (countries ordered by decreasing rank of total health expenditure per capita in US$
Purchasing Parity Power)
Women Stomach Colon Rectum Lung Melanoma NHLa
RS% Cases RS% Cases RS% Cases RS% Cases RS% Cases RS% Cases
Switzerland 30 91 57 305 60 163 13 201 84 65 44 83
Germany 29 430 56 986 54 500 9 306 92 122 52 167
Franceb 25 296 55 870 59 494 16 182 79 122 43 280
Denmark 13 601 47 3096 44 1486 5 2728 83 655 45 751
Norway 20 880 53 2675 55 1243 9 1230 86 713 48 672
The Netherlandsb 24 553 52 1607 53 683 10 827 88 230 43 467
Austria 39 242 59 310 45 154 16 155 83 84 42 69
Iceland 22 45 51 72 49 28 9 107 100 13 52 16
Swedenb 19 1397 55 4420 55 2238 10 2027 86 1115 48 1382
Italy 27 3510 51 5167 46 2199 8 2767 75 600 44 1842
Finland 23 1064 50 1585 48 941 9 1056 78 381 41 850
United Kingdom 13 8706 45 22,190 45 10,529 6 27,824 80 3417 40 6331
Spain 30 920 54 1425 52 746 10 396 88 210 49 469
Portugal 24 225 42 213 40 140 – – 59 36 38 70
Slovenia 16 498 40 503 31 488 8 347 59 102 38 178
Czeck Republic 15 226 38 373 36 229 7 156 77 80 42 85
Slovakia 16 1023 42 1193 30 1031 10 576 57 208 34 232
Poland 10 453 27 662 28 424 6 1004 49 104 29 202
Estonia 19 609 36 519 23 321 11 311 51 79 35 68
RS%, relative survival (%).
a Non-Hodgkin’s Lymphoma.
b Information from death certificates not available to the cancer registries (see text).
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of the variables we used is given here.
The indicators were divided into four groups: a group with
macro-economic factors (values in US dollars at PurchasingPower Parity -US$ PPP-), including gross domestic product
(GDP) and total health expenditure (THE); a group including
the percentages of labour force employed in agriculture,
industry and services; a group with the characteristics of
Table 1c – Relative survival (%) at 5 years from diagnosis for women aged 65–84 years diagnosed during the period 1990–
94, by cancer site and country (countries ordered by decreasing rank of total health expenditure per capita in US$
Purchasing Parity Power)
Women Breast Cervix uteri Corpus uteri Ovary
RS% Cases RS% Cases RS% Cases RS% Cases
Switzerland 78 768 48 44 70 168 16 139
Germany 78 1654 55 136 79 538 32 284
Francea 78 2178 55 172 66 416 26 295
Denmark 72 5588 48 676 77 1646 24 1196
Norway 76 3948 52 432 71 976 27 975
The Netherlandsa 77 3588 50 202 71 634 23 559
Austria 75 672 50 73 81 185 33 145
Iceland 78 142 53 14 61 33 42 37
Swedena 82 10,086 49 699 76 2656 31 1895
Italy 79 10,349 49 787 70 2168 24 1536
Finland 78 4008 44 271 77 1238 24 885
United Kingdom 68 43,142 41 3525 66 7114 21 9070
Spain 76 3403 58 259 69 812 32 416
Portugal 74 441 38 68 – – 39 71
Slovenia 65 1182 40 166 69 443 23 243
Czeck Republic 64 597 50 86 66 272 19 156
Slovakia 58 2046 36 440 55 1020 26 474
Poland 61 1453 39 364 60 482 22 405
Estonia 61 714 48 258 55 319 15 294
RS%, relative survival (%).
a Information from death certificates not available to the cancer registries (see text).
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ment (total health employment (TE), and total number of
practitioners (TP), both per 1000 population), and medical
technologies (computed tomography scanners (CTS), and
equipment for nuclear magnetic resonance (ENMR), all per
1,000,000 population); and a group describing demographic
factors, including marital status (proportion of population
aged 65 years and older who were married and widowed)
and household composition (the percentage of households
with 1, 2, or 3 or more persons). The demographic indicators
were taken from 1991 censuses, while all other factors related
to period from 1993 to 1995.
Relative survival was correlated with socio-economic fac-
tors at the national level using Pearson’s correlation (r) [15].
3. Results
3.1. Correlation between relative survival, and
macro-economic factors and medical resources
Table 2 gives the correlations between cancer survival at 5
years from diagnosis for patients aged from 65 to 84 years,
by cancer site and sex; the variables of the macro-economic
group (GDP and THE); the percentage of labour force em-
ployed in agriculture (AGR); and medical resources (CTS and
ENMR, TE and TP). The correlations for GDP and THE were
highly positive for nearly all the cancer sites. Most, including
those for cancers of the colon, rectum, melanoma, breast,
uterus, prostate and NHL were close to or above 0.70, whereas
those for stomach were lower, around 0.50–0.55. The correla-
tions for lung and ovary were much lower. There were no
marked differences by sex in the correlations with GDP andTHE. All the correlations between cancer survival and the per-
centage of labour force employed in agriculture were nega-
tive; the coefficients were mostly around 0.60 or less, but
there was little or no correlation for stomach, lung, cervix
uteri and ovary. For CTS and ENMR very high, positive and
statistically significant correlations (from around 0.5 to 0.8)
were observed for most of the cancer sites, the exceptions
being lung and ovary. Unlike CTS and ENMR, the levels of
equipment for radiotherapy did not show any relationship
with cancer survival (data not shown). The correlations for
TE were lower than for CTS and ENMR: those for four of the
cancers, colon (in women), rectum, melanoma and breast,
were statistically significant at around 0.5–0.65. There was
no association between TP and survival for any of the 11
cancers.
3.2. Correlation between relative survival and
demographic factors
Table 3 gives the correlations between the proportions of
married people and cancer survival in the total population,
and between the proportions of the population by marital
status and cancer survival in the elderly. Almost all of the
correlations between the proportion of married people in
the total population and cancer survival were small and
numerically negative, and none was statistically significant.
The survival of elderly women was generally more strongly
related to marital status than that for men. There were sta-
tistically significant correlations between the proportion of
elderly married people and survival of around 0.5–0.8 for
cancers of the colon, rectum, melanoma, breast and cervix
in women, and for stomach and lung in men. Apart from
Table 2 – Correlation (r) between macro-economic factors, labour force employed in agriculture, and health care resources
with relative survival at 5 years from diagnosis in patients aged 65–84 years diagnosed during the period 1990–1994, by
sex and cancer site
Macro-economic factors Labour force Health care resources
GDP THE AGR CTS ENMR TE TP
W M W M W M W M W M W M W M
Stomach 0.50 0.51 0.54 0.57 0.38 0.36 0.69* 0.73* 0.52 0.53 0.10 0.21 0.26 0.28
Colon 0.87* 0.78* 0.86* 0.78* 0.78* 0.74* 0.79* 0.58* 0.73* 0.59* 0.48 0.47 0.18 0.23
Rectum 0.90* 0.83* 0.90* 0.83* 0.69* 0.63* 0.68* 0.69* 0.71* 0.73* 0.66* 0.64* 0.11 0.13
Lung 0.24 0.42 0.32 0.48 0.15 0.28 0.43 0.37 0.34 0.18 0.15 0.01 0.07 0.09
Melanoma 0.82* 0.80* 0.79* 0.83* 0.68* 0.73* 0.76* 0.68* 0.67* 0.72* 0.51 0.60* 0.03 0.08
Breast 0.83* 0.82* 0.63* 0.74* 0.67* 0.51 0.29
Cervix uteri 0.53 0.57 0.44 0.52 0.44 0.22 0.22
Corpus uteri 0.70* 0.68* 0.69* 0.55 0.53 0.20 0.02
Ovary 0.25 0.22 0.10 0.41 0.21 0.11 0.04
Prostate 0.66* 0.70* 0.52 0.84* 0.63* 0.43 0.16
NHLa 0.67* 0.65* 0.63* 0.68* 0.58* 0.55 0.81* 0.70* 0.66* 0.51 0.11 0.19 0.06 0.13
r Values are Pearson’s correlation coefficients with an indication of their statistical significance (P < 0.05, *P < 0.01). GDP, gross domestic product
(per capita, US$ Purchasing Power Parity). THE, total health expenditure (per capita, US$ Purchasing Power Parity). AGR, labour force employed
in agriculture per 100. CTS, number of computed tomography scanners per 1,000,000 population. ENMR, number of equipments for nuclear
magnetic resonance per 1,000,000 population. TE, number of total health employment per 1000 population. TP, number of total practitioners
per 1000 population. W, women, M, men. All data refer to the period 1993–1995.
a Non-Hodgkin’s lymphoma.
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widowed people were negative, but only those for rectum,
melanoma and breast in women were statistically signifi-
cant. The correlations between the proportions of never
married elderly people and cancer survival were moderate,
mostly in the range 0.25–0.5 and not statistically significant;
the exceptions were for breast cancer, and rectal cancer in
men.
In Table 4 the correlations between the proportions of the
population by household composition and cancer survival in
the elderly are given. There was generally no relationship
for the proportion of one person households, the exception
being for melanoma in men. The correlations for the propor-Table 3 – Correlation (r) between marital status (proportion in
patients aged 65–84 years diagnosed during the period 1990–1
Total population
Married Married
W M W
Stomach 0.01 0.11 0.18
Colon 0.25 0.07 0.57
Rectum 0.20 0.37 0.79*
Lung 0.14 0.03 0.11
Melanoma 0.39 0.28 0.61 
Breast 0.37 0.66*
Cervix uteri 0.27 0.49
Corpus uteri 0.16 0.22
Ovary 0.47 0.30
Prostate 0.21
NHLa 0.30 0.15 0.22
r Values are Pearson’s correlation coefficients with an indication of thei
demographic data are from 1991 censuses.
a Non-Hodgkin’s Lymphoma.tion of households composed of two people were generally
positive, those for colon, rectum and melanoma in both
sexes, and breast and corpus uteri were in the range 0.5–
0.75 and statistically significant. The correlations for the pro-
portion of households with three or more people generally
exhibited a weaker and inverse pattern to that for the propor-
tion of two person households.
3.3. Correlation between relative survival and THE, CTS
Fig. 1 illustrates the correlation of relative survival by country
for stomach and colon cancers (both sexes combined), breast
and prostate cancers with THE; and Fig. 2 the correlation withcountry) and relative survival at 5 years from diagnosis in
994, by sex and cancer site
Elderly 65–84 years
Widowed Never married
M W M W M
0.50 0.20 0.23 0.46 0.34
0.34 0.42 0.38 0.39 0.29
0.11 0.55 0.48 0.38 0.59
0.71 0.25 0.25 0.27 0.27
0.06 0.73* 0.44 0.38 0.39
0.57 0.52
0.31 0.42
0.31 0.23
0.34 0.23
0.41 0.32 0.45
0.34 0.34 0.35 0.33 0.42
r statistical significance (P < 0.05, *P < 0.01). W, women; M, men. All
Table 4 – Correlation (r) between household composition (proportion in country) and relative survival at 5 years from
diagnosis in patients aged 65–84 years diagnosed during the period 1990–1994, by sex and cancer site
% 1 Persona % 2 Personsa % P3 Personsa
W M W M W M
Stomach 0.11 0.11 0.12 0.12 0.01 0.02
Colon 0.35 0.31 0.56 0.56 0.40 0.37
Rectum 0.30 0.43 0.67* 0.69* 0.47 0.55
Lung 0.20 0.15 0.01 0.09 0.12 0.10
Melanoma 0.35 0.64 0.72* 0.75* 0.50 0.67*
Breast 0.36 0.54 0.39
Cervix uteri 0.20 0.28 0.15
Corpus uteri 0.40 0.53 0.40
Ovary 0.08 0.04 0.02
Prostate 0.33 0.39 0.27
NHLb 0.26 0.05 0.34 0.22 0.21 0.03
r Values are Pearson’s correlation coefficients with an indication of their statistical significance (P < 0.05, *P < 0.01). All demographic data are
from 1991 censuses.
a % of households with 1 person, 2 persons, 3 or more persons on total number of households. W, women; M, men.
b Non-Hodgkin’s lymphoma.
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were variables which were generally highly related to survival
and describe important aspects of the health care systems.
We have included stomach, colon, breast and prostate can-
cers because of their high incidence in the elderly population
and their positive relationships with the socio-economic
indicators.
Survival for stomach was generally low, with similar val-
ues in both poor and more affluent countries; the UK and
Denmark, despite their higher values of THE, had similar sur-
vival to the Eastern European countries. For colon and breast
cancers the correlation with THE was stronger, but over about
US$ 1600 there were only small differences in survival among
the countries. There was much wider variability in survival
for prostate cancer, which increased with THE up to around
80% in France and Germany, which had the highest THE val-
ues (around US$ 2000) except for Switzerland; Denmark had
by far the lowest survival among Western and Northern Euro-
pean countries.
The number of CTS (per million population) was highly
correlated with survival for all four cancer sites. For stomach
and prostate cancers, the charts show a clear linear relation-
ship, with survival rates increasing progressively from the
countries with fewer than 5 CTS up to those with the highest
number (around 20). For colon and breast cancers, survival
generally increased only up to around 10 CTS.
4. Discussion
4.1. Cancer survival, macro-economic factors and medical
resources
The affluence of a country, represented by GDP and THE, was
very strongly related to survival in the elderly for most of the
11 major cancer sites we studied. The correlation was strong
for cancers with a reasonably good prognosis in the elderly;
but for cancers of the stomach and cervix uteri the associa-
tion was much less strong, and no association was observed
for cancers of the lung and ovary which have quite poor sur-vival. It appears that the affluence of even the most developed
European countries has little effect on survival for lung and
ovary cancers, for which clinical treatment is generally not
very effective. Clinical management through major surgery
or complex chemotherapeutic regimens is often difficult to
apply in elderly patients, who are often suffering from a het-
erogeneous group of co-morbid conditions and have physio-
logical impairment [16]. For stomach and cervix uteri
cancers the situation is more complex. The partial lack of cor-
relation for stomach is due to the variation in case mix,
among the European countries: the Northern countries and
the UK have a subsite distribution different from the South-
ern countries, with a higher percentage of proximal locations
(cardia and fundus) which have a poorer prognosis [17]. If we
exclude these countries from the analysis, the correlation be-
tween stomach cancer survival and the independent vari-
ables would be more marked. Indeed, the low survival in
affluent countries, such as the UK, The Netherlands and
Scandinavian countries, is consistent with the association be-
tween high socio-economic status and tumour characteristics
with adverse prognostic factors, such as advanced stage at
diagnosis, cardia subsite and diffuse histology type [18,19]. El-
derly women have a high rate of under- or non-use of cervical
screening and are likely to be lifelong under-utilisers, proba-
bly with a higher incidence of cervical cancer than screened
women [20]. Cervical cancer has reasonably good prognosis
in young women but survival quickly decreases with age.
The relative risks for older women versus the middle aged
of dying from cervical cancer were among the highest of all
cancers, 1.8 and 1.3 at 1 and 5 years from diagnosis, respec-
tively, with the largest disadvantage in the most elderly
patients [4]. In most of the population-based studies examin-
ing early diagnosis and disease extension, cervix uteri pre-
sented more often than other cancers at an advanced stage
in elderly patients. Treatment in elderly women is often less
aggressive than in younger women – and the elderly are more
likely to receive no treatment at all [21,22]. Thus not only is
invasive cervical cancer more common at older ages, but
the survival of elderly women is worse [23].
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1990–1994, and total health expenditure (per capita, US$ Purchasing Parity Power), in patients aged 65–84 years (both sexes
combined for stomach and colon cancers). r Values are Pearson’s correlation coefficients with an indication of their statistical
significance (P < 0.05, *P < 0.01). PPP, Purchasing Power Parity. *, countries in bold type and underlined: organised mass
screening in place during the incidence period (1990–1994). A, Austria; CZ, Czech Republic; DK, Denmark; EST, Estonia; FIN,
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coefficients were similar to those for GDP and THE, and just
a little higher than those for ENMR. As for the health person-
nel indicators, TE correlated quite well with survival, whereas
TP did not. Our results are consistent with other analyses that
showed, in Western countries, that GDP had a closer relation-
ship with the number of nurses than with the number of gen-
eral practitioners [24]. In some countries, such as Spain and
Italy, the number of physicians (per head of population) is
much higher than elsewhere, and there is an imbalance in
the ratio of graduate and non-graduate staff, which is not in
accordance with the recommendations of the World Bank
[25].
4.2. Cancer survival and demographic factors
Marital status played a very important role: for several cancer
sites including colon, rectum and breast which have high
incidence, survival was related positively with the proportion
of married elderly women in the population and negatively
with the proportion of widows. Marital status did not how-
ever, have the same relevance for women for all ages com-
bined. There was a marked difference between the sexes:
survival for elderly men generally did not appear to be influ-
enced by these types of demographic factors. Demographic
factors could play a major role in determining health out-
comes in elderly women, by affecting access to health care
and delay in diagnosis.These results confirm our previous comparisons between
cancer survival in elderly and middle aged adults. Cancer pa-
tients aged over 65 years experienced much higher risks of
dying than younger adults, particularly at 1 year from diagno-
sis and for those cancers for which disease stage was the
main prognostic determinant. Furthermore, the disadvantage
of elderly women was larger than that of elderly men [4].
Being married or widowed is for elderly people, in particu-
lar elderly women, an important factor influencing psycho-
logical status, life habits, social relationships and the use of
support services offered by the community [26]. Elderly wo-
men are more likely to have a lower degree of social indepen-
dence on account of, for example, having lower income and
educational levels than elderly men, and to lack easy access
to transport. Furthermore, they have often outlived their hus-
bands, often have disabilities, and often need home care [27].
Large population-based studies have shown that insufficient
social support is a risk factor for lower cancer survival [28].
In the elderly, survival for several of the major cancers was
related to the proportion of two person households. Two peo-
ple living together would be able to provide reciprocal social
support, whereas families with three or more members could
be associated with relatively low affluence, and many more
problems of social dependence.
One might have expected strong negative correlations be-
tween cancer survival and the percentage of families with one
person, but we found generally only weak positive relation-
ships. Unfortunately, with the available data we could not
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only one person would include a large number of young peo-
ple living alone.
5. Conclusions
In the elderly, the correlation between GDP and survival was
strong for most cancer sites. However, the countries with
the highest THE did not always have the highest survival rates
(particularly for breast and prostate cancers) and over a level
of expenditure of around US$ 1600, survival did not improve
further. Some authors have claimed that increases in THE
above a fairly high threshold does not always correspond with
further improvement in health performance [29–32].
All European countries have been trying to provide their
populations with equal access to health care, but remarkable
differences still exist [33]. Countries with similar total GDP ob-
tain better health outcomes when the distribution of income
is more egalitarian [34].
A particular role is played by factors related indirectly to
social support. These observations could have remarkable
consequences for health spending, because the number of el-
derly people is rising and they use health care services at a
higher rate than young people [27]. A social network to help
elderly people to cope with cancer and its therapies is becom-
ing increasingly important, especially now that the number of
elderly people living alone is also rising [34]. Suitable choicesof social policy and specific health care plans should therefore
be high priority in order to maintain both good health and
quality of life in elderly people.
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